ライフサイエンスコーパス: gastrointestinal hemorrhage

1 in cohort 2 (three neutropenia and two upper gastrointestinal hemorrhage).

2 certainty) but did not increase frequency of gastrointestinal hemorrhage.

3 s of all patients who underwent VA for lower gastrointestinal hemorrhage.

4 in England following hospital admission for gastrointestinal hemorrhage.

5 es in patients with severe nonvariceal upper gastrointestinal hemorrhage.

6 estive heart failure, pneumonia, sepsis, and gastrointestinal hemorrhage.

7 py improves the outcome of nonvariceal upper gastrointestinal hemorrhage.

8 One patient suffered a postoperative gastrointestinal hemorrhage.

9 be associated with an increased incidence of gastrointestinal hemorrhage.

10 neumonia, sepsis, electrolyte disorders, and gastrointestinal hemorrhage.

11 tigraphy in the localization of active lower gastrointestinal hemorrhage.

12 esophageal varices are a rare cause of upper gastrointestinal hemorrhage.

13 rare and can lead to clinically significant gastrointestinal hemorrhage.

14 risk of bleeding, including intracranial and gastrointestinal hemorrhage.

15 d early aspirin did not have higher rates of gastrointestinal hemorrhage (0.8% aspirin vs 0.7% no asp

16 r aleglitazar vs 2.8% for placebo, P = .14), gastrointestinal hemorrhages (2.4% for aleglitazar vs 1.

17 tachycardia (3%), thoracic pain (3%), upper gastrointestinal hemorrhage (3%), and vomiting (3%).

18 y all-cause mortality rates among those with gastrointestinal hemorrhage (5.0% vs 5.8%; adjusted mort

19 n percent of patients had moderate or severe gastrointestinal hemorrhage, 6.4% had moderate or severe

20 ter kidney transplantation, 10 patients with gastrointestinal hemorrhage, 8 patients with head-and-ne

21 79 patients (4.8%), including 276 (48%) with gastrointestinal hemorrhage, 83 (14%) with hemorrhagic s

22 ratio = 0.96; 95% CI, 0.93-0.99; p = 0.021), gastrointestinal hemorrhage (adjusted odds ratio = 1.70;

23 ratio = 2.27; 95% CI, 1.22-4.24; p = 0.010), gastrointestinal hemorrhage (adjusted odds ratio = 2.01;

24 reatment and outcomes of patients with upper gastrointestinal hemorrhage admitted to major teaching h

25 a aspiration, ventricular tachycardia, upper gastrointestinal hemorrhage, anaphylactic reaction, acut

26 the developing world, are a leading cause of gastrointestinal hemorrhage and iron deficiency anemia.

27 hrough which these parasitic nematodes cause gastrointestinal hemorrhage and iron deficiency anemia.

28 atient in the dexamethasone group had occult gastrointestinal hemorrhage and one patient in each grou

29 In the ablation group, one patient had upper gastrointestinal hemorrhage, and five patients (6.0%) ha

30 ncidence of ventilator-associated pneumonia, gastrointestinal hemorrhage, and in-hospital mortality r

31 00-299 mm Hg (aOR, 1.76; 95% CI, 1.37-2.25), gastrointestinal hemorrhage (aOR, 1.69; 95% CI, 1.42-2.0

32 pitals (OR, 1.32; 95% CI, 1.14-1.53) and for gastrointestinal hemorrhage at urban hospitals (OR, 1.15

33 a) ventilator-associated pneumonia; b) upper gastrointestinal hemorrhage; c) bacteremia; d) barotraum

34 Massive upper gastrointestinal hemorrhage can be the dominant symptom

35 s positive localization of the site of lower gastrointestinal hemorrhage compared with VA alone.

36 rhage, and death and increased risk of major gastrointestinal hemorrhage compared with warfarin in el

37 One patient had a serious upper gastrointestinal hemorrhage considered unrelated to test

38 ollowing both nonvariceal and variceal upper gastrointestinal hemorrhage decreased from 1999 to 2007,

39 He died after severe gastrointestinal hemorrhage developed.

40 complications included toxemia, lupus flare, gastrointestinal hemorrhage due to Mallory-Weiss tear, p

41 nes mortality associated with variceal upper gastrointestinal hemorrhage during an 11-year period by

42 nt visceral angiography (VA) for acute lower gastrointestinal hemorrhage from January 1, 2005, to Dec

43 ntrolled trial of patients with severe upper gastrointestinal hemorrhage from ulcers or other lesions

44 National Health Service hospital, for upper gastrointestinal hemorrhage, from 1999 to 2007 (n=516,15

45 nemia grade 3, 1 thrombocytopenia grade 4, 1 gastrointestinal hemorrhage grade 3, and 1 acute kidney

46 higher bleeding incidence in GVHD was due to gastrointestinal hemorrhage, hemorrhagic cystitis, and p

47 ial infarction, heart failure, acute stroke, gastrointestinal hemorrhage, hip fracture, and percutane

48 ion, congestive heart failure, acute stroke, gastrointestinal hemorrhage, hip fracture, and pneumonia

49 ial infarction (AMI), heart failure, stroke, gastrointestinal hemorrhage, hip fracture, or pneumonia,

50 7; 95% CI, 1.04-2.38; P = .03), particularly gastrointestinal hemorrhage (HR, 2.24; 95% CI, 1.29-3.90

51 ver diseases; alcohol-related liver disease; gastrointestinal hemorrhage; human immunodeficiency infe

52 hovah's Witness presented with massive upper gastrointestinal hemorrhage; initial hemoglobin was 3.5

53 tis, esophagitis, gastrointestinal ischemia, gastrointestinal hemorrhage, intestinal obstruction, par

54 It is unclear whether mortality from upper gastrointestinal hemorrhage is changing: any differences

55 Hospital mortality, intracranial and gastrointestinal hemorrhage, major transfusion.

56 ce of diagnostic imaging when managing lower gastrointestinal hemorrhage may reduce subsequent morbid

57 ration (n = 6), postoperative ileus (n = 3), gastrointestinal hemorrhage (n = 2), delayed splenic rup

58 ompared mortality for patients admitted with gastrointestinal hemorrhage (n = 39,409) or acute myocar

59 4; 10%) elevated transaminases (n = 4; 10%), gastrointestinal hemorrhage (n = 5; 12.5%), wound infect

60 atio, 0.35 [CI, 0.31 to 0.40]), and previous gastrointestinal hemorrhage (odds ratio, 0.47 [CI, 0.40

61 : acute myocardial infarction, hip fracture, gastrointestinal hemorrhage, pneumonia, sepsis, and stro

62 CI 63-86%), cirrhosis (PPV 60%; 47-73%), and gastrointestinal hemorrhage (PPV 62%; 51-73%) had improv

63 nemia, intestinal infection, liver diseases, gastrointestinal hemorrhage, renal failure, urinary trac

64 ocytopenia, hepatitis, vascular leakage, and gastrointestinal hemorrhage, resulting in uniform lethal

65 In patients with upper gastrointestinal hemorrhage, teaching hospitals do not a

66 bitors (coxibs) were developed to cause less gastrointestinal hemorrhage than nonselective nonsteroid

67 of selected patients with nonvariceal upper gastrointestinal hemorrhage (UGIH) has been proposed as

68 Triage of patients with acute upper gastrointestinal hemorrhage (UGIH) has traditionally req

69 The rate of minor gastrointestinal hemorrhage was increased.

70 mally incorporated CTA to manage acute lower gastrointestinal hemorrhage was launched after multidisc

71 Minor, but not major, gastrointestinal hemorrhage was more common in the early

72 dy of 124 patients admitted with acute upper gastrointestinal hemorrhage was performed.

73 stroke of any severity, major bleeding, and gastrointestinal hemorrhage were lower in the centrifuga

74 th severe, life-threatening anemia caused by gastrointestinal hemorrhage who refused all blood produc